Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
Search for stocks (e.g., AAPL, GOOGL, AMZN)

KPTI

NGS
Karyopharm Therapeutics Inc.
HealthcareDrug Manufacturers - Specialty & Generic
Watchlist:
Last updated: Friday 4th July 2025
4.39
-0.22 (-4.77%)
Prev Close:4.61
Open:4.69
Bid:4.43
Ask:4.6
52 Week Range
3.51
16.95
Volume:78,714
Mkt Cap:38 M
Price Target
$5.05
+15.0%
Metrics

Growth

EPS
QoQ
N/A
YoY
N/A
Revenue
QoQ
N/A
YoY
N/A
Free Cash Flow
QoQ
N/A
YoY
N/A

Peers

Peers data not available
Available data keys: fn_01356, peerValues

Risk

Financial Health

Cash Metrics
Liquidity Ratios
Financial Scores

Technicals

Technical Oscillators
Volatility Metrics
Financials

Financial Statements

KPTI - Income Statement (Annual)

Dec-24Dec-23Dec-22Dec-21Dec-20Dec-19Dec-18Dec-17Dec-16Dec-15
Depreciation And Amortization621000.0789000.01000000.01000000.0-700000.0-713000.0-717000.0-634000.0
Gain On Sale Of Security90000.0500000.0
General And Administrative Expense115 M132 M145 M144 M126 M105 M49 M25 M24 M22 M
Gross Profit Margin (profit Margin After CGS)145 M146 M152 M206 M105 M41 M30 M2 M154000.0250000.0
Interest Expense Non Operating37 M24 M25 M26 M27 M16 M2 M
Misc Other Special Charges73 M-356000.0-83000.0-85000.0206000.0-50000.0-33000.0-81000.010000.0-2000.0
Net Income (loss)-76 M-143 M-165 M-124 M-196 M-200 M-178 M-129 M-110 M-118 M
Net Income Common Stockholders-76 M-143 M-165 M-124 M-196 M-200 M-178 M-129 M-110 M-118 M
Net Income Continuous Operations-76 M-143 M-165 M-124 M-196 M-200 M-178 M-129 M-110 M-118 M
Net Non Operating Interest Income Expense7 M11 M-23 M-25 M-24 M-10 M2 M2 M1 M897000.0
Operating Income-119 M-130 M-142 M-98 M-172 M-189 M-180 M-131 M-111 M-119 M
Operating Income Before Depreciation (EBITDA)-39 M-141 M-139 M-95 M-168 M-177 M-174 M-127 M-108 M-116 M
Operating Expense265 M276 M294 M308 M280 M230 M210 M-132 M-111 M-119 M
Other Gand A115 M132 M145 M144 M126 M105 M49 M25 M24 M22 M
Other Operating Expenses3 M3 M3 M3 M3 M2 M-210 M-132 M-111 M-119 M
Rent And Landing Fees-2 M25 M24 M22 M
Research Expense143 M139 M149 M161 M151 M122 M161 M107 M87 M98 M
Salaries And Wages18 M22 M35 M30 M3 M2 M-17 M-20 M-22 M-17 M
Selling And Marketing Expense126 M105 M49 M
Selling Expense126 M105 M49 M
Total Income Available For Interest Expense (EBIT)-39 M-143 M-140 M-98 M-169 M-184 M-176 M-129 M-109 M-118 M
Total Revenues145 M146 M157 M210 M108 M41 M30 M2 M154000.0250000.0
Total Expenses265 M276 M299 M311 M280 M230 M210 M-132 M-111 M-119 M
Total Revenue145 M146 M157 M210 M108 M41 M30 M2 M154000.0250000.0
Avgshs121863.08 M82 M5 M4802.04 M4 M3 M3 M2 M
Avgshsdt126809.08 M82 M5 M4802.04 M4 M3 M3 M2 M
Basiceps-0.63-18.75-2.02-24.75-2.72-3.22
Basicepscont-0.63-18.75-2.02-24.75
Cor5 M3 M3 M
Depamor621000.0789000.01000000.01000000.0-700000.0-713000.0-717000.0-634000.0
Dileps-0.93-18.75-2.02-24.75-40.8-48.3-47.1-42.15-43.8-49.8
Dilepscont-0.93-18.75-2.02-40.8-48.3-47.1
Intinc7 M11 M2 M582000.03 M5 M4 M2 M1 M897000.0
Netincdisc-76 M-143 M-165 M-124 M-196 M-200 M-178 M-129 M-110 M-118 M
Othincexp-73 M356000.0-83000.085000.0-206000.050000.033000.081000.0-10000.02000.0
Pretaxinc-76 M-143 M-165 M-124 M-196 M-200 M-178 M-129 M-109 M-118 M
Resdev143 M139 M149 M161 M151 M122 M161 M107 M87 M98 M
Sga115 M132 M145 M144 M126 M105 M49 M25 M24 M22 M
Shsout126 M8 M113 M5 M5 M4 M4 M3 M3 M2 M
Taxprov57000.0323000.0369000.0268000.0309000.040000.026000.063000.0139000.0
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement "your own" investment strategies in Excel with thousands of MarketXLS functions and templates.
MarketXLS provides all the tools I need for in-depth stock analysis. It's user-friendly and constantly improving. A must-have for serious investors.

John D.

Financial Analyst

I have been using MarketXLS for the last 6+ years and they really enhanced the product every year and now in the journey of bringing in AI...

Kirubakaran K.

Investment Professional

MarketXLS is a powerful tool for financial modeling. It integrates seamlessly with Excel and provides real-time data.

David L.

Financial Analyst

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel.

Lloyd L.

Professional Trader